Global technology company Philips touts FDA clearance for its MicroDose SI mammography platform.
Technology giant Philips (NYSE:PHG) won FDA clearance for its MicroDose SI full-field mammography system, which the company hopes to leverage as a platform new mammogram imaging applications.
The system promises reduced radiation dosages in producing high quality images, 5-minute exam times and ergonomic design with curved and warmed breast support.